Multi-35 Sub-Study A: Phase 1b/2 Subprotocol of ASP-1929 Photoimmunotherapy in Combination with anti-PD1 Therapy in Patients with Head and Neck Squamous Cell Carcinoma

Grants and Contracts Details

StatusFinished
Effective start/end date11/10/20 → 5/15/23

Funding

  • Rakuten Medical Incorporated: $142,355.00